Table 1

Results of univariate analyses to investigate risk factors for three different clinical outcomes.

>5 days poorly>5 days pain or frequency>5 days ‘out of action’
n (%)OR (95% CI)n (%)OR (95% CI)n (%)OR (95% CI)
Sensitive to all151/476 (31.7)Ref132/457 (28.9)Ref70/493 (14.2)Ref
Resistance to at least one antibiotic154/389 (39.6)1.41 (1.07 to 1.87)146/378 (38.6)1.55 (1.16 to 2.07)98/410 (23.9)1.90 (1.35 to 2.67)
Resistance to ampicillin137/341 (40.2)1.45 (1.08 to 1.93)127/332 (38.3)1.53 (1.13 to 2.06)85/360 (23.6)1.87 (1.32 to 2.65)
Resistance to trimethoprim74/147 (50.3)2.18 (1.50 to 3.18)80/141 (56.7)3.23 (2.19 to 4.77)51/154 (33.1)2.99 (1.97 to 4.56)
Treated with antibiotic resistant to
 No234/728 (32.1))Ref212/703 (30.2)Ref126/754 (16.7))Ref
 Yes55/95 (57.9)2.9 (1.88 to 4.49)52/94 (55.3)2.87 (1.85 to 4.44)34/98 (34.7)2.65 (1.68 to 4.19)
Sex
 Male36/84 (42.9)Ref28/74 (37.8)Ref29/86 (33.7)Ref
 Female272/790 (34.4)0.7 (0.44 to 1.11)253/769 (32.9)0.81 (0.49 to 1.32)141/827 (17.0)0.4 (0.25 to 0.65
Any comorbidity
 No85/296 (28.7)Ref83/288 (28.8)Ref45/307 (14.7)Ref
 Yes223/578 (38.6)1.56 (1.15 to 2.11)198/555 (35.7)1.37 (1.01 to 1.87)125/606 (20.6)1.51 (1.04 to 2.20)
Bladder operation
 No260/784 (33.2)Ref239/758 (31.5)Ref146/817 (17.9)Ref
 Yes47/80 (58.8)2.87 (1.80 to 4.59)39/76 (51.3)2.29 (1.42 to 3.68)23/85 (27.1)11.71 (1.02 to 2.84)
Catheter
 No216/668 (32.3)Ref197/654 (30.1)Ref115/702 (16.4)Ref
 Yes88/188 (46.8)1.84 (1.33 to 2.56)77/171 (45.0)1.90 (1.35 to 2.68)52/191 (27.2)1.91 (1.31 to 2.78)
Diabetes
 No287/414 (35.3)Ref258/787 (32.8)Ref157/850 (18.5)Ref
 Yes20/56 (35.7)1.02 (0.58 to 1.80)21/53 (39.6)1.35 (0.76 to 2.38)12/59 (20.3)1.13 (0.58 to 2.17)
  • OR = odds ratio.